Dose escalation studies are typically conducted in the early phases (Phase I and Phase II) of clinical trials. These studies involve gradually increasing the dose of a drug administered to participants to determine the maximum tolerated dose (MTD), the optimal biological dose (OBD), and the recommended dose for further studies.
